scholarly article | Q13442814 |
P2093 | author name string | Gang Chen | |
Ping Li | |||
Ping Yan | |||
Lihong Xu | |||
Michele Wible | |||
Demei Zhu | |||
Yingyuan Zhang | |||
Yijian Chen | |||
Yongjie Zhao | |||
M Anne Hickman | |||
Margaret Tawadrous | |||
Xiajun Xu | |||
P2860 | cites work | Interval estimation for the difference between independent proportions: comparison of eleven methods | Q56475155 |
Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010 | Q84502640 | ||
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]. | Q24813784 | ||
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America | Q28268745 | ||
Two-sided confidence intervals for the single proportion: comparison of seven methods | Q28271313 | ||
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection | Q30275008 | ||
Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study. | Q30828046 | ||
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data | Q30998307 | ||
Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial | Q33642184 | ||
Antibiotic management of complicated intra-abdominal infections in adults: The Asian perspective. | Q34829365 | ||
Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial | Q37593067 | ||
Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial. | Q38474221 | ||
Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials | Q38895819 | ||
Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole | Q38972381 | ||
Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resista | Q40517201 | ||
Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China | Q40783326 | ||
A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections | Q42952452 | ||
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China | Q45275409 | ||
In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). | Q46334700 | ||
Tigecycline is efficacious in the treatment of complicated intra-abdominal infections. | Q50161651 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hospitalization | Q3140971 |
imipenem/cilastatin | Q6004128 | ||
P304 | page(s) | 2327-2339 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | Therapeutics and Clinical Risk Management | Q15766913 |
P1476 | title | A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China | |
P478 | volume | 14 |
Q90437573 | Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: A Bayesian network meta-analysis of randomized clinical trials | cites work | P2860 |
Search more.